Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve

Candela Juan1,2, Loreana Gallo1,3, Noelia Gonzalez Vidal4,5

  • 1Departamento de Biología, Bioquímica y Farmacia-Universidad Nacional del Sur (UNS), Bahía Blanca, Buenos Aires, Argentina.

AAPS Pharmscitech
|April 8, 2024
PubMed

Insights

This study developed orally disintegrating tablets (ODTs) for pediatric arterial hypertension treatment using losartan potassium. The ODTs demonstrated rapid drug release and stability, offering a promising new dosage form for children.

Area of Science:

  • Pharmacology
  • Pharmaceutical Technology
  • Pediatric Medicine

Background:

  • Effective pharmacological treatment in children requires suitable dosage forms.
  • Orally disintegrating tablets (ODTs) offer advantages like ease of administration and dosage accuracy, particularly for pediatric patients.
  • Arterial hypertension in children necessitates specialized and accessible treatment options.

Purpose of the Study:

  • To develop and characterize orally disintegrating tablets (ODTs) containing losartan potassium (LP) for treating arterial hypertension in children.
  • To evaluate the impact of various superdisintegrants and diluents on ODT properties.
  • To assess the in vitro performance and preliminary stability of the developed ODTs.

Main Methods:

  • Losartan potassium ODTs were formulated using direct compression with different superdisintegrants and diluents.
  • Thirty formulations were evaluated for disintegration time, hardness, and friability.
  • Drug-excipient compatibility, tabletability, flow properties, in vitro dissolution, and preliminary stability were assessed.

Main Results:

  • Two formulations met optimal criteria for disintegration time (<30 s), hardness, and friability (≤1.0%).
  • Developed ODTs exhibited favorable drug-excipient compatibility, tabletability, and flow characteristics.
  • In vitro dissolution studies showed very rapid drug release, and stability studies indicated the need for protective packaging, with retained quality after 12 months in airtight containers.

Conclusions:

  • Successfully developed and characterized losartan potassium ODTs suitable for pediatric use.
  • The ODTs represent a potential advancement in the treatment of childhood arterial hypertension.
  • Further development into a final prototype is warranted to improve pediatric hypertension management.

Related Concept Videos

Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
133
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
826
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
428
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
613
Routes of Drug Administration: Enteral01:18

Routes of Drug Administration: Enteral

Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
3.6K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
720